Skip to main content
. 2022 Oct 1;52:101669. doi: 10.1016/j.eclinm.2022.101669

Table 2.

Incremental cost-effectiveness ratios per country, comparing community-based postdischarge malaria chemoprevention (PDMC) with facility-based PDMC, and with the national standard of care.

Cost (USDa)
Effectiveness (QALYb)
Cost-effectiveness
Country Strategy Health care provider cost Household cost Total cost Incremental cost HALEc Incremental QALY ICERd
Malawi Standard of care 36·00 8·91 44·84 52·65 negative
PDMC Facility-delivered 19·50 11·65 31·11 −13·72 52·98 0·33 negative
PDMC Community-delivered 16·95 5·83 22·74 −8·37 53·03 0·05 dominant
Kenya Standard of care 46·63 29·98 76·40 53·86 negative
PDMC Facility-delivered 26·27 23·47 51·49 −24·91 54·20 0·34 negative
PDMC Community-delivered 22·54 15·72 37·87 −13·61 54·25 0·05 dominant
Uganda Standard of care 41·95 14·16 56·00 53·84 negative
PDMC Facility-delivered 22·46 18·44 40·84 −15·16 54·18 0·34 negative
PDMC Community-delivered 19·33 10·50 29·78 −11·07 54·23 0·05 dominant

Incremental cost-effectiveness rankings per country. This table reports mean values from Monte-Carlo simulations of 10·000 iterations per country. Confidence intervals are shown as 95% confidence interval ellipsoids in Figures 3a-c; an extended version of this table with confidence intervals of the mean values is shown in the supplementary materials, Table S9. When comparing the three strategies, Community-delivered PDMC was the absolute dominant strategy: it was at the same time the least costly over the expected lifetime of a child (lowest cost per QALY gained) and yielded the most health-adjusted life-years. The incremental quality-adjusted life years (QALY) specify each strategy's expected impact on mortality and morbidity. The incremental values indicate that the facility-based distribution also absolutely dominates the standard of care. However, it is less cost-saving and less effective than community-based distribution when compared to standard of care.

a

USD– United States Dollar.

b

QALY– Quality-adjusted life years.

c

HALE– Health-adjusted life expectancy.

d

ICER– Incremental cost-effectiveness ratio.